Teresa (Teri) Foy is an immunologist with 30 years of experience in the biotechnology and pharmaceutical industry developing novel therapeutics in the areas of oncology and inflammation. Teri is currently leading Bristol Myers Squibb’s (BMS) Cancer Immunology and Cellular Therapy Thematic Research Center (CICT TRC), focused on discovery, pre-clinical development and translational research of BMS’s Cancer Immunology and Cell Therapy pipeline. She is a member of BMS’s Research Leadership Team as well as the Cell Therapy Leadership Team. Teri also serves as the site head for BMS Seattle

Share: